386 related articles for article (PubMed ID: 24392842)
21. Targeting high mobility group box 1 as a late-acting mediator of inflammation.
Czura CJ; Tracey KJ
Crit Care Med; 2003 Jan; 31(1 Suppl):S46-50. PubMed ID: 12544976
[TBL] [Abstract][Full Text] [Related]
22. Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo.
Yang EJ; Lee W; Song KS; Bae JS
Biochem Pharmacol; 2016 Jun; 110-111():58-70. PubMed ID: 27106082
[TBL] [Abstract][Full Text] [Related]
23. JH-4 reduces HMGB1-mediated septic responses and improves survival rate in septic mice.
Lee W; Yuseok O; Yang S; Lee BS; Lee JH; Park EK; Baek MC; Song GY; Bae JS
J Cell Biochem; 2019 Apr; 120(4):6277-6289. PubMed ID: 30378167
[TBL] [Abstract][Full Text] [Related]
24. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.
Zhu S; Li W; Ward MF; Sama AE; Wang H
Inflamm Allergy Drug Targets; 2010 Mar; 9(1):60-72. PubMed ID: 19906009
[TBL] [Abstract][Full Text] [Related]
25. Suppressive effects of rare ginsenosides, Rk1 and Rg5, on HMGB1-mediated septic responses.
Kim JE; Lee W; Yang S; Cho SH; Baek MC; Song GY; Bae JS
Food Chem Toxicol; 2019 Feb; 124():45-53. PubMed ID: 30496780
[TBL] [Abstract][Full Text] [Related]
26. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department.
Sama AE; D'Amore J; Ward MF; Chen G; Wang H
Acad Emerg Med; 2004 Aug; 11(8):867-73. PubMed ID: 15289194
[TBL] [Abstract][Full Text] [Related]
27. Extracellular HMGB1 as a therapeutic target in inflammatory diseases.
Andersson U; Yang H; Harris H
Expert Opin Ther Targets; 2018 Mar; 22(3):263-277. PubMed ID: 29447008
[TBL] [Abstract][Full Text] [Related]
28. Ameliorative Effect of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) on HMGB1-Induced Septic Responses In Vitro and In Vivo.
Lee W; Kim KM; Bae JS
Am J Chin Med; 2015; 43(5):991-1012. PubMed ID: 26224030
[TBL] [Abstract][Full Text] [Related]
29. An ongoing search for potential targets and therapies for lethal sepsis.
Bao GQ; He L; Lee D; D'Angelo J; Wang HC
Mil Med Res; 2015; 2():20. PubMed ID: 26257917
[TBL] [Abstract][Full Text] [Related]
30. Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice.
Chang KC
Thromb Res; 2015 Aug; 136(2):456-64. PubMed ID: 26116490
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of polyozellin from Polyozellus multiplex on HMGB1-mediated septic responses.
Yang EJ; Ku SK; Lee W; Song KS; Bae JS
Inflamm Res; 2015 Sep; 64(9):733-46. PubMed ID: 26206236
[TBL] [Abstract][Full Text] [Related]
32. HMGB1 activity inhibition alleviating liver injury in heatstroke.
Tong H; Tang Y; Chen Y; Yuan F; Liu Z; Peng N; Tang L; Su L
J Trauma Acute Care Surg; 2013 Mar; 74(3):801-7. PubMed ID: 23425738
[TBL] [Abstract][Full Text] [Related]
33. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1.
Li W; Ashok M; Li J; Yang H; Sama AE; Wang H
PLoS One; 2007 Nov; 2(11):e1153. PubMed ID: 17987129
[TBL] [Abstract][Full Text] [Related]
34. The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity.
Li L; Lu YQ
Front Immunol; 2020; 11():601815. PubMed ID: 33552058
[TBL] [Abstract][Full Text] [Related]
35. Anti-septic effects of pellitorine in HMGB1-induced inflammatory responses in vitro and in vivo.
Ku SK; Lee IC; Kim JA; Bae JS
Inflammation; 2014 Apr; 37(2):338-48. PubMed ID: 24077682
[TBL] [Abstract][Full Text] [Related]
36. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
Lee W; Ku SK; Bae JS
Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
[TBL] [Abstract][Full Text] [Related]
37. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.
Tang D; Kang R; Xiao W; Zhang H; Lotze MT; Wang H; Xiao X
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):651-60. PubMed ID: 19265175
[TBL] [Abstract][Full Text] [Related]
38. High-mobility group box 1 (HMGB1) protein: friend and foe.
Ulloa L; Messmer D
Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria.
Chorny A; Anderson P; Gonzalez-Rey E; Delgado M
J Immunol; 2008 Jun; 180(12):8369-77. PubMed ID: 18523304
[TBL] [Abstract][Full Text] [Related]
40. Anti-septic effects of fisetin in vitro and in vivo.
Yoo H; Ku SK; Han MS; Kim KM; Bae JS
Inflammation; 2014 Oct; 37(5):1560-74. PubMed ID: 24706001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
